Report Detail
Europe Drug Delivery Systems Market to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others) and Geography
- RnM3599566 |
- 16 July, 2019 |
- Global |
- 235 Pages |
- The Insight Partners |
- Other
The Europe drug delivery systems market is expected to reach US$ 610,320.4 Mn in 2027 from US$ 343,533.9 in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.
Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions in Europe is expected to foster the growth of the Europe drug delivery systems market. On the other hand, regulatory recalls for drug delivery systems by European manufacturers are likely to create a negative impact on the market growth to an extent. However, the development of drug delivery devices to cater to the increasing infectious disease incidence in Europe is expected to offer growth opportunities for market players in the region over the course of years.
Europe has a huge pool of patient population suffering from various chronic disease conditions. Europe is highly affected by non-communicable diseases that include cardiovascular diseases, diabetes, cancer, mental disorders, and chronic respiratory diseases. According to the World Health Organization (WHO) 2016, these five major diseases collectively account for 77% of the total disease burden in the European region. WHO Europe states that approximately 17 million people across the globe due to cardiovascular diseases. According to the European Heart Network (EHN), cardiovascular diseases account for 45% of deaths in Europe and 37% deaths in the European Union. In addition, diseases of respiratory systems are also one of the main factors contributing to the European disease burden. This disease majorly deals with the oral passage, nasal cavity, larynx, pharynx, trachea, and bronchitis. According to Europa, the statistical portal, the standardized death rate in Europe due to chronic respiratory diseases was recorded to be 88.4 deaths per 100,000 populations in 2015. Furthermore, diabetes being one of the leading global factors for mortality also significantly affect death rates in Europe. According to the World Health Organization (WHO), about 60 million patients in Europe suffer due to diabetes, of which majority of patients have obesity, physical inactivity, and unhealthy diets as prime reasons for the cause of the disease. Owing to a high prevalence of chronic diseases across the European region, the market for drug delivery systems is expected to witness a rising growth o over the coming years.
The drug delivery systems market on the basis of route of administration is majorly classified into oral, transmucosal, injectable, topical, implantable, and ocular. In 2018, the oral segment held the largest market share of 50.2% of the drug delivery systems market, by route of administration. The oral segment is expected to dominate its market share in 2027 owing to ease of drug administration, a high degree of flexibility on dosages, and cost-effectiveness. Moreover, the oral segment is expected to be the most preferred type of route of administration.
Some of the major primary and secondary sources for drug delivery systems included in the report are European Heart Network (EHN), Food and Drug Administration (FDA), World Health Organization, European Health Management Association (EHMA), European Medicines Agency (EMA) and others.
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
2. Europe Drug Delivery Systems Market – Key Takeaways
3. Europe Drug Delivery Systems Market – Market Landscape
- 3.1 Overview
- 3.2 Market Segmentation
- 3.2.1 Europe Drug Delivery Systems Market – By Route of Administration
- 3.2.2 Europe Drug Delivery Systems Market – By Application
- 3.2.3 Europe Drug Delivery Systems Market – By Distribution Channel
- 3.2.4 Europe Drug Delivery Systems Market – By Country
- 3.3 PEST Analysis
4. Europe Drug Delivery Systems Market - Key Market Dynamics
- 4.1 Key Market Drivers
- 4.1.1 Rising Investments by Pharmaceutical and Medical Device Companies in R&D
- 4.1.2 Rise of Chronic Disease Conditions in Europe
- 4.2 Key Market Restraints
- 4.2.1 Recent Product Recalls for Drug Delivery Systems in Europe
- 4.3 Key Market Opportunities
- 4.3.1 Growing Prevalence of Infectious Diseases
- 4.4 Future Trends
- 4.4.1 New Drug Delivery Systems In Development
- 4.5 Impact Analysis
5. Drug Delivery Systems Market – Europe Analysis
- 5.1 Europe Drug Delivery Systems Market Revenue Forecasts And Analysis
- 5.2 Market Positioning
- 5.3 Performance Of Key Players
6. Europe Drug Delivery Systems Market Analysis – By Route Of Administration
- 6.1 Overview
- 6.2 Europe Drug Delivery Systems Market, By Route of Administration, 2018 & 2027 (%)
- 6.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
- 6.4 Oral Drug Delivery Market
- 6.4.1 Overview
- 6.4.2 Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.4.3 Solid Oral Drugs Market
- 6.4.3.1 Overview
- 6.4.3.2 Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
- 6.4.4 Liquid Oral Drugs Market
- 6.4.4.1 Overview
- 6.4.4.2 Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
- 6.4.5 Semi-Solid Oral Drugs Market
- 6.4.5.1 Overview
- 6.4.5.2 Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5 Transmucosal Drug Delivery Market
- 6.5.1 Overview
- 6.5.2 Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.3 Pulmonary Drug Delivery Market
- 6.5.3.1 Overview
- 6.5.3.2 Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.3.3 In-metered Dose Inhalers Market
- 6.5.3.3.1 Overview
- 6.5.3.3.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.3.4 Dry Powder Inhalers Market
- 6.5.3.4.1 Overview
- 6.5.3.4.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.3.5 Nebulizers Market
- 6.5.3.5.1 Overview
- 6.5.3.5.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.4 Nasal Drug Delivery Market
- 6.5.4.1 Overview
- 6.5.4.2 Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.4.3 Nasal Spray Market
- 6.5.4.3.1 Overview
- 6.5.4.3.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.4.4 Nasal Drops Market
- 6.5.4.4.1 Overview
- 6.5.4.4.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.4.5 Nasal Gel Market
- 6.5.4.5.1 Overview
- 6.5.4.5.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.5 Buccal Drug Delivery Market
- 6.5.5.1 Overview
- 6.5.5.2 Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.6 Sublingual Drug Delivery Market
- 6.5.6.1 Overview
- 6.5.6.2 Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.7 Rectal Transmucosal Drug Delivery Market
- 6.5.7.1 Overview
- 6.5.7.2 Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5.8 Vaginal Transmucosal Drug Delivery Market
- 6.5.8.1 Overview
- 6.5.8.2 Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.6 Topical Drug Delivery Market
- 6.6.1 Overview
- 6.6.2 Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.6.3 Semi-solid Topical Drug Delivery Formulations Market
- 6.6.3.1 Overview
- 6.6.3.2 Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
- 6.6.4 Liquid Topical Drug Delivery Formulations Market
- 6.6.4.1 Overview
- 6.6.4.2 Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
- 6.6.5 Solid Topical Drug Delivery Formulations Market
- 6.6.5.1 Overview
- 6.6.5.2 Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
- 6.6.6 Transdermal Patches Market
- 6.6.6.1 Overview
- 6.6.6.2 Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)
- 6.6.7 Transdermal Gels Market
- 6.6.7.1 Overview
- 6.6.7.2 Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)
- 6.6.8 Others Market
- 6.6.8.1 Overview
- 6.6.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
- 6.7 Injectable Drug Delivery Market
- 6.7.1 Overview
- 6.7.2 Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.7.3 Conventional Injection Devices Market
- 6.7.3.1 Overview
- 6.7.3.2 Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)
- 6.7.4 Self-Injection Devices Market
- 6.7.4.1 Overview
- 6.7.4.2 SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)
- 6.7.4.3 Needle Free Injectors Market
- 6.7.4.3.1 Overview
- 6.7.4.3.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
- 6.7.4.4 Pen injectors Market
- 6.7.4.4.1 Overview
- 6.7.4.4.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
- 6.7.4.5 Wearable Injectors Market
- 6.7.4.5.1 Overview
- 6.7.4.5.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
- 6.8 Implantable Drug Delivery Market
- 6.8.1 Overview
- 6.8.2 Implantable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.8.3 Active Implantable Market
- 6.8.3.1 Overview
- 6.8.3.2 Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)
- 6.8.4 Passive Implantable Market
- 6.8.4.1 Overview
- 6.8.4.2 Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)
- 6.9 Ocular Drug Delivery Market
- 6.9.1 Overview
- 6.9.2 Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
- 6.9.3 Eye Drops and Sprays Market
- 6.9.3.1 Overview
- 6.9.3.2 Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)
- 6.9.4 Gels & Ointments Market
- 6.9.4.1 Overview
- 6.9.4.2 Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)
- 6.9.5 Ocular Inserts Market
- 6.9.5.1 Overview
- 6.9.5.2 Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)
- 6.9.6 Drug Coated Contact Lens Market
- 6.9.6.1 Overview
- 6.9.6.2 Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)
7. Europe Drug Delivery Systems Market Analysis – By Application
- 7.1 Overview
- 7.2 Europe Drug Delivery Systems Market, By Application, 2018 & 2027 (%)
- 7.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
- 7.4 Homecare Settings Market
- 7.4.1 Overview
- 7.4.2 Europe Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.5 Hospitals & Clinics Market
- 7.5.1 Overview
- 7.5.2 Europe Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.6 Others Market
- 7.6.1 Overview
- 7.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Drug Delivery Systems Market Analysis – By Distribution Channel
- 8.1 Overview
- 8.2 Europe Drug Delivery Systems Market, By Distribution Channel, 2018 & 2027 (%)
- 8.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
- 8.4 Hospital Pharmacies Market
- 8.4.1 Overview
- 8.4.2 Europe Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5 Retail Pharmacies Market
- 8.5.1 Overview
- 8.5.2 Europe Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.6 Online Pharmacies Market
- 8.6.1 Overview
- 8.6.2 Europe Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027
- 9.1.1 Overview
- 9.1.2 Europe Drug Delivery Systems Market revenue Overview, by Country (2017) (US$ Mn)
- 9.1.3 Europe Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.4 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
- 9.1.4.1 Europe Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.4.2 Europe oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.4.3 Europe Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.4.4 Europe Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.4.5 Europe Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.4.6 Europe Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.4.7 Europe Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.4.8 Europe Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.4.9 Europe Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.5 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.6 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
- 9.1.7 Europe Drug Delivery Systems Market Revenue and Forecasts to 2027, By Country (%)
- 9.1.8 Germany Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.9 Germany Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.9.1 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
- 9.1.9.1.1 Germany Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.9.1.2 Germany Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.9.1.3 Germany Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.9.1.4 Germany Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.9.1.5 Germany Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.9.1.6 Germany Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.9.1.7 Germany Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.9.1.8 Germany Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.9.2 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.9.3 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
- 9.1.10 France Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.11 France Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.11.1 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
- 9.1.11.1.1 France Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.1.2 France Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.1.3 France Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.1.4 France Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.1.5 France Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.1.6 France Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.1.7 France Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.1.8 France Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.1.9 France Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.11.2 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.11.3 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
- 9.1.12 UK Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.13 UK Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.13.1 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
- 9.1.13.1.1 UK Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.1.2 UK Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.1.3 UK Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.1.4 UK Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.1.5 UK Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.1.6 UK Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.1.7 UK Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.1.8 UK Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.1.9 UK Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.1.13.2 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.13.3 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10. Drug Delivery Systems Market – Industry Landscape
- 10.1 Overview
- 10.2 Comparative Company Analysis
- 10.3 Growth Strategies Done by the Companies in the Market, (%)
- 10.4 Organic Developments
- 10.4.1 Overview
- 10.5 Inorganic Developments
- 10.5.1 Overview
11. Drug Delivery Systems Market–Key Company Profiles
- 11.1 3M
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Financial Overview
- 11.1.4 Product Portfolio
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 BD
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Financial Overview
- 11.2.4 Product Portfolio
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Boston Scientific Corporation
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Financial Overview
- 11.3.4 Product Portfolio
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 Novo Nordisk A/S
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Financial Overview
- 11.4.4 Product Portfolio
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Bausch Health Companies Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Financial Overview
- 11.5.4 Product Portfolio
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Baxter International, Inc.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Financial Overview
- 11.6.4 Product Portfolio
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 Boehringer Ingelheim International Gmbh
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Financial Overview
- 11.7.4 Product Portfolio
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 Novartis AG
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Financial Information
- 11.8.4 Product Portfolio
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 GlaxoSmithKline Plc.
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Financial Overview
- 11.9.4 Product Portfolio
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 Terumo Corporation
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Financial Overview
- 11.10.4 Product portfolio
- 11.10.5 SWOT ANALYSIS
- 11.10.6 Key Developments
- 11.11 Johnson & Johnson Services, Inc.
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Financial Overview
- 11.11.4 Product Portfolio
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary Of Terms
- 12.3 Methodology
- 12.3.1 Coverage
- 12.3.2 Secondary Research
Summary:
Get latest Market Research Reports on Europe Drug Delivery Systems . Industry analysis & Market Report on Europe Drug Delivery Systems is a syndicated market report, published as Europe Drug Delivery Systems Market to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others) and Geography. It is complete Research Study and Industry Analysis of Europe Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
